Ampio granted IND for inhaled COVID-19 therapy September 21, 2020 -- Ampio Pharmaceuticals has received Investigational New Drug (IND) authorization from the U.S. Food and Drug Administration, allowing it to conduct additional clinical trials to test Ampion inhalation therapy for patients with COVID-19.
Integral Molecular touts PA grant to advance COVID-19 research September 21, 2020 -- Integral Molecular was awarded over $520,000 from the state of Pennsylvania to leverage its technologies in COVID-19 research. The grant will enable the company and its partners to develop therapies and vaccines against SARS-CoV-2.
PharmAbcine, Samsung Biologics expand partnership September 21, 2020 -- PharmAbcine and Samsung Biologics have entered into a new strategic partnership for the development and manufacturing of PMC-403, a next-generation antibody therapeutic candidate to treat neovascular disorders.
Axon Neuroscience to research COVID-19 vaccine September 18, 2020 -- Clinical-stage biotechnology company Axon Neuroscience plans to start clinical trials of an independently developed, crowdfunded vaccine against COVID-19 called ACvac1.
Elicio, Moffitt to study combination CAR-T therapy September 18, 2020 -- Elicio Therapeutics and the Moffitt Cancer Center have established a collaboration to study Elicio's amphiphile immunotherapies with CD19 chimeric antigen receptor-T (CAR-T) cells.